NAGIOS: RODERIC FUNCIONANDO

Adverse systemic reaction to benznidazole.

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Adverse systemic reaction to benznidazole.

dc.contributor.author	Pacheco Coronel, Maria Verónica
dc.contributor.author	Oriente Frutos, Laura
dc.contributor.author	Calabuig Muñoz, Eva
dc.contributor.author	Kury Valle, Diana
dc.contributor.author	Hernández Fernández de Rojas, Dolores
dc.date.accessioned	2017-05-08T08:10:44Z
dc.date.available	2017-05-08T08:10:44Z
dc.date.issued	2017
dc.identifier.citation	Pacheco Coronel, Maria Verónica Oriente Frutos, Laura Calabuig Muñoz, Eva Kury Valle, Diana Hernández Fernández de Rojas, Dolores 2017 Adverse systemic reaction to benznidazole. Revista Da Sociedade Brasileira de Medicina Tropical 50 1 145 147
dc.identifier.uri	http://hdl.handle.net/10550/58383
dc.description.abstract	Benznidazole, drug of choice for Chagas disease (CD), has been associated with a high incidence of adverse reactions that can become serious, necessitating discontinuation of the drug. We describe the case of a Bolivian patient living in Spain for 9 years, who, following treatment with benznidazole for CD in indeterminate chronic phase, presented with fever, skin lesions, digestive symptoms, general malaise, and laboratory abnormalities. After the discontinuation of benznidazole and, the intake of antihistamines and systemic corticosteroids, the patient presented a complete resolution of the symptoms. Optimization of dose strategies and development of more effective, and better-tolerated drugs is advisable.
dc.language.iso	eng
dc.relation.ispartof	Revista Da Sociedade Brasileira de Medicina Tropical, 2017, vol. 50, num. 1, p. 145-147
dc.subject	Farmacologia
dc.subject	Chagas, Malaltia de
dc.title	Adverse systemic reaction to benznidazole.
dc.type	journal article	es_ES
dc.date.updated	2017-05-08T08:10:44Z
dc.identifier.idgrec	117280
dc.rights.accessRights	open access	es_ES